Preferred Name |
Dolutegravir |
|
Synonyms |
|
|
ID |
http://www.phoc.org.cn/pmo/class/PMO_00025993 |
|
Database_Cross_Reference |
SNOMEDCT_US:713464000 VANDF:4032640 USPMG:MTHU002715 NCI_FDA:DKO1W9H7M1 MTH:NOCODE MMSL:29613 ATC:J05AX12 MEDCIN:343271 NDDF:015174 RXNORM:1433868 MSH:C562325 DRUGBANK:DB08930 MTHSPL:DKO1W9H7M1 LNC:LP157327-0 LNC:MTHU045713 MMSL:d08117 NCI:C121543 NDFRT:N0000188383 SNOMEDCT_US:714767001 |
|
label |
Dolutegravir |
|
MCID |
MC00883289 |
|
PMOID |
PMO:00025993 |
|
prefixIRI |
pmo:PMO_00025993 |
|
prefLabel |
Dolutegravir |
|
Synonym |
DOLUTEGRAVIR dolutegravir (medication) DTG Dolutegravir (substance) Dolutegravir (product) 2H-Pyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazine-9-carboxamide, N-((2,4-difluorophenyl)methyl)-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-, (4R,12aS) dolutegravir (4R,9aS)-5-hydroxy-2-methyl-6,10-dioxo-3,4,6,9,9a,10-hexahydro-2H-1-oxa-4a,8a-diaza-anthracene-7-carboxylic acid- 2,4 difluorobenzylamide 2H-Pyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazine-9- carboxamide, N-((2,4-difluorophenyl)methyl)-3,4,6,8,12,12a- hexahydro-7-hydroxy-4-methyl-6,8-dioxo-, (4R,12aS)- antiretrovirals dolutegravir |
|
Tree Number |
T6.4.2.4.1.7.6 T6.4.2.4.1.4.6 |
|
subClassOf |